Mir Mubashir Khalid retweeted
Peptides have become the latest cure-all trend on social media, but is the hype warranted? Deepak Srivastava warns that public enthusiasm may have surpassed the science.
go.nature.com/4aXDa6j
You’ve heard of Schrödinger’s cat: dead and alive at the same time.
Well, now we have the Strait of Hormuz: open and closed at the same time.
Do your New Year resolutions include a plan to leave higher education? These researchers explain how to reinvent your career.
go.nature.com/4sD0FJg
Mir Mubashir Khalid retweeted
Natural daylight and improved glucose control in Type 2 diabetes
cell.com/cell-metabolism/ful… @Cell_Metabolism
Mir Mubashir Khalid retweeted
For the #organoid research group that I founded at the Princess Máxima Center, we are looking for a motivated postdoc with experience in gene editing and bioinformatics. Contact Karin Sanders ([email protected]) to learn more. @prinsesmaximac
Mir Mubashir Khalid retweeted
We are looking for a postdoc in virology/immunology at the Ignaz Semmelweis Institute at the Medical University in Vienna.
meduniwien.ac.at/web/karrier…
Mir Mubashir Khalid retweeted
🧵 Why the obsession with p < 0.05 is hurting science. A meme. A truth. A reality check.
Mir Mubashir Khalid retweeted
Imagine having your name chosen by literature laureate Rabindranath Tagore, that is what happened to Amartya Sen. Tagore suggested Sen’s unusual first name to his mother. 'Amartya' means immortal (Bengali অমর্ত্য ômorto, lit. "immortal"). Read Sen's article on Tagore: bit.ly/2HKLdrt
Mir Mubashir Khalid retweeted
Open position for a talented student in my group at @IHB_Research . Working closely with @AntonioSantinha , you will have the opportunity to use organoids, immune cell co-cultures and high-content CRISPR screens to study CRC carcinogenesis. go.roche.com/r7syy
Mir Mubashir Khalid retweeted
Melanie Ott (@TheOttLab)talks about the ongoing measles outbreak, explains how vaccination can lower the risk of Alzheimer’s, and shares other positive “side effects” of vaccines.
bit.ly/41FTZ08
Mir Mubashir Khalid retweeted
In an interview with @amfAR, Melanie Ott (@TheOttLab), discusses the future of HIV research, and describes how lessons from the field have laid a strong foundation for fighting other viral diseases.
bit.ly/4ijGbj8
Mir Mubashir Khalid retweeted
Virologist Melanie Ott (@TheOttLab) speaks to @KUSINews about the measles outbreak and other infectious diseases
bit.ly/4bzFek9
Mir Mubashir Khalid retweeted
Exclusive: These universities have the most retracted scientific articles
A first-of-its-kind analysis reveals which institutions are retraction hotspots
Read the full story here: go.nature.com/4gMhkmG
Mir Mubashir Khalid retweeted
1) Since there is a lot of confusion about the reduction of the overhead rate on NIH grants to 15% (see here: grants.nih.gov/grants/guide/…) I'll do a little tweetorial (or X-torial?) about it.
Mir Mubashir Khalid retweeted
In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research
go.nature.com/4gclXG0
Mir Mubashir Khalid retweeted
Postdoc fellowship for applicants from ASEAN countries. Great opportunity to do a postdoc in Singapore! See list of PIs working on infectious diseases. snas.org.sg/saseaf
Mir Mubashir Khalid retweeted
The Hoffmann lab is thrilled to announce that we are now a part of the @GladstoneInst! We are so grateful for the opportunity to continue our research among such talented and influential scientists.
Magnus Hoffmann opened his lab at Gladstone Institutes earlier this year with a mission to create a vaccine platform that provides long-lasting immune protection against a wide range of pathogens.
Read more: bit.ly/4hDlmzm






















